Back to Journals Drug Design, Development and Therapy Volume 20 Efimosfermin for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Mechanism of Action, Clinical Development and Emerging Therapeutic Potential Authors Alamgir M , Sohal A , Kowdley KV Received 6 January 2026 Accepted for publication 19 March 2026 Published 31 March 2026 Volume 2026:20 560039 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Anastasios Lymperopoulos Mariam Alamgir, 1 Aalam Sohal, 1, 2 Kris V Kowdley 1, 3 1 Department of Hepatology, Liver Institute Northwest, Seattle, WA, USA
( ) -
As weve discussed, reactive hypoglycemia refers to the occurrence of post-meal low blood sugar (i.e., postprandial hypoglycemia) two to five hours after someones last meal
Cummings and Schnellmann, 2002
Stopping weight loss treatment has been shown to result in weight regain
The difference is rarely the technique